Early clinical studies showed that high-dose vitamin C, given by intravenous and oral routes,
may improve symptoms and prolong life in patients with terminal cancer. Double-blind …

In the 1970s, P auling and C ameron reported increased survival of patients with advanced
cancer treated with high‐dose intravenous (IV) vitamin C (L‐ascorbate, ascorbic acid) …

Background. Intravenous vitamin C (IVC) is a contentious adjunctive cancer therapy, widely
used in naturopathic and integrative oncology settings. We conducted a systematic review of …

In 2008, we celebrate the 80th anniversary of the discovery of vitamin C. Since then, we
know that vitamin C possesses few pharmacological actions although it is still perceived by …

Background Biological and some clinical evidence suggest that high-dose intravenous
vitamin C (IVC) could increase the effectiveness of cancer chemotherapy. IVC is widely used …

Background: Vitamin C at high concentrations is toxic to cancer cells in vitro. Early clinical
studies of vitamin C in patients with terminal cancer suggested clinical benefit, but 2 double …

The use of intravenous vitamin C (IVC) for cancer therapy has long been an area of intense
controversy. Despite this, high dose IVC has been administered for decades by …

In recent years, the idea that Vitamin C (Vit-C) could be utilized as a form of anti-cancer
therapy has generated many contradictory arguments. Recent insights into the physiological …

Mounting evidence indicates that vitamin C has the potential to be a potent anti-cancer
agent when administered intravenously and in high doses (high-dose IVC). Early phase …

This article reviews intravenous vitamin C (IV C) in cancer care and offers a rational
approach to enable medical oncologists and integrative practitioners to safely provide IV C …